Skip to content

    Archean Chemical

    ACI
    Chemicals·31 Jul 2025
    Management Summary

    Archean Chemical reported a strong Q1 FY26 with consolidated revenue growing 30% YoY to ₹300.59 crores, driven by stable volumes in Bromine and Industrial Salt. While standalone EBITDA grew 13% YoY, consolidated net profit was impacted by initial losses from subsidiaries. The company is making progress on strategic initiatives like SOP commercialization and Oren Hydrocarbon's revival, with sales expected from Q3 FY26, and remains net debt-free.

    Highlights

    6

    • Consolidated revenue grew 30% year-on-year to ₹300.59 crores in Q1 FY26.

    • Standalone EBITDA increased 13% YoY to ₹95.8 crores, maintaining a strong margin of 32.86%.

    • Elemental Bromine and Industrial Salt volumes remained stable, with Bromine sales at 4,054 tons and Salt sales at 1.1 million tons.

    • Sulphate of Potash (SOP) trial runs are progressing well, with plant modifications underway for commercial scale trials, and meaningful contributions expected in H2 FY26.

    • Oren Hydrocarbon (Idealis Mudchemie) has commenced trial runs and product qualification, with commercial production and sales expected to start in Q3 FY26.

    • Company remains net debt-free, backed by a robust balance sheet and disciplined capital allocation.

    Concerns

    3

    • Consolidated Net Profit at ₹40.14 crores was lower than standalone PAT of ₹51.85 crores, primarily due to initial losses from subsidiaries (Acume Chemicals and Idealis Chemicals).

    • The chemical industry is experiencing mixed trends and tariff uncertainties, impacting global MNC decisions.

    • External sales of Elemental Bromine declined from 4,700 tons in the prior year quarter to approximately 3,600 tons this quarter, a point management agreed to clarify later.

    Key financials

    Single quarter

    08 metrics
    1. 01Consolidated Revenue₹300.59 Cr+30%YoY
    2. 02Consolidated EBITDA₹86.32 Cr
    3. 03Consolidated Net Profit₹40.14 Cr
    4. 04Consolidated EBITDA Margin28.7%
    5. 05Standalone Revenue₹291.5 Cr+30%YoY

    Segment breakdown

    • Industrial Salt₹194 Cr64.4%
    • Elemental Bromine₹84 Cr27.9%
    • Sulphate of Potash (SOP)₹0.26 Cr0.1%
    • Bromine Derivatives₹23 Cr7.6%
    Donut· Share of Revenue

    Capital allocation

    3
    CategoryHeadline
    Debt

    Net ₹0 crores

    M&A

    Oren Hydrocarbon (renamed Idealis Mudchemie)

    acquisition · integrated

    M&A

    Offgrid Energy Labs

    acquisition · pending regulatory

    Guidance & targets

    7
    CategoryTargetPriority
    Volume
    Elemental Bromine Volume Growth
    gradual improvement
    		Medium
    Volume
    Industrial Salt Volume
    maintain 1.1 million tons and increase
    		Medium
    Profitability
    SOP Contribution
    meaningful contributions
    		Medium
    Capacity
    Bromine Derivatives Capacity Utilization
    >50%
    		Medium
    Revenue
    Oren Hydrocarbon (Idealis Mudchemie) Revenue
    INR 150 crores
    		Medium
    Project Timeline
    Oren Hydrocarbon Sales Start
    start from the third quarter
    		High
    Project Timeline
    Offgrid Energy Labs Gigafactory Materialization
    18 to 24 months
    		Medium

    SOP Commercial Contribution

    H2 FY26
    CurrentTrial runs progressing, plant modifications underway
    TargetMeaningful contributions in H2 FY26

    Why it matters

    SOP is expected to be a mainstay business and a key growth driver, with commercialization impacting future profitability.

    And we continue to believe that SOP will be a mainstay business for the company in the quarters and years to come. ... As stated earlier, we expect meaningful contributions from this vertical in the second half of FY '26.

    How to verify

    guidance_and_targets

    Risks & concerns

    5
    RiskSeverity

    Mixed trends and tariff uncertainties in chemical industry

    Witnessing mixed trends across the chemical industry with early signs of recovery in select segments, but recent tariff uncertainties have held back global MNCs. — Management acknowledged

    medium

    Challenging pricing environment

    The pricing environment has been challenging for the chemical industry over the last couple of years, though Archean has seen some uptick. — Management acknowledged

    medium

    Initial losses from new subsidiaries

    Subsidiaries like Acume Chemicals and Idealis Mudchemie are incurring initial losses in their first year of operation, impacting consolidated PAT. — Management acknowledged

    medium

    Delays in Oren Hydrocarbon ramp-up and technical approvals

    Product certification and technical approvals for Oren Hydrocarbon are taking longer than anticipated, potentially impacting FY26 revenue guidance. — Management acknowledged

    medium

    Potential ban on certain flame retardants

    Analyst raised concern about global news regarding bans on toxic flame retardants; management noted regulations exist for certain categories but there's a large arena of products, promising clarity later. — Analyst acknowledged

    low

    Q&A highlights

    8

    “As you are all aware, these are long-term contracts that we have in place. And I think customers continue reporting faith in both the supply side with us as well as their own operations where they continue to consume. So at the moment, both remain strong for us, and the off take continues almost at 100% of what we make, we are able to sell.”

    Analyst questioned confidence in Bromine growth guidance (20-25%) given weak global demand; management reiterated strength of long-term contracts and 100% off-take.

    asked by Aditya Khetan

    2 min read5 chapters

    Detailed Narrative

    01

    Q1 FY26 Financial Performance Overview

    Archean Chemical reported a robust Q1 FY26, with consolidated revenue reaching ₹300.59 crores, marking a 30% year-on-year growth. Standalone revenue stood at ₹291.5 crores, also up 30% YoY. Standalone EBITDA was ₹95.8 crores, a 13% YoY increase, with a margin of 32.86%. However, consolidated net profit was ₹40.14 crores, lower than standalone PAT of ₹51.85 crores, primarily due to initial losses from new subsidiaries.

    02

    Segmental Performance and Product Mix

    Elemental Bromine contributed approximately 30% of total standalone revenue, with sales volume of 4,054 tons, and prices have seen an uptick, now closer to USD 2.5/kg. Industrial Salt contributed around 70% of standalone revenue, with sales volume maintained at 1.1 million tons. Sulphate of Potash (SOP) generated ₹0.26 crores from 52 metric tons, with trial runs progressing well. Bromine Derivatives operations are at 30-40% capacity utilization, contributing approximately ₹23 crores in revenue.

    03

    Strategic Initiatives: Oren Hydrocarbon and Energy Storage

    The acquired Oren Hydrocarbon (renamed Idealis Mudchemie) has made steady progress in revival, with trial runs commenced and product qualification underway. Commercial production and sales are expected to start in Q3 FY26, with a FY26 revenue guidance of ₹150 crores. In energy storage, Archean acquired an 18.14% stake in Offgrid Energy Labs, a zinc-bromide battery innovator, with plans to scale up to a gigafactory within 18-24 months after successful pilot execution.

    04

    Market Trends and Outlook

    The chemical industry is experiencing mixed trends, with early signs of recovery in select segments, but recent tariff uncertainties are impacting global MNCs. Despite these challenges, Archean has demonstrated resilience, with strong customer relationships and long-term contracts providing stability. The Indian specialty chemicals industry is poised for long-term growth, supported by domestic consumption and government incentives.

    05

    Operational Efficiency and Logistics

    Operational challenges, particularly related to logistics, have been largely resolved through the addition of equipment and improved site operations, contributing to increased sales volumes. The company has also implemented strategies like purchasing extra raw material as a buffer to mitigate risks from unseasonal rains and ensure continuous shipments, especially for salt exports.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.